TRISALUS LIFE SCIENCES
TriSalus Life Sciences, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The company's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
TRISALUS LIFE SCIENCES
Industry:
Biotechnology Developer Platform Hardware Medical
Founded:
2009-01-01
Address:
Westminster, Colorado, United States
Country:
United States
Website Url:
http://www.trisaluslifesci.com
Total Employee:
11+
Status:
Active
Contact:
3034261223
Email Addresses:
[email protected]
Total Funding:
125.65 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF SSL By Default HSTS IPv6 Microsoft Exchange Online Office 365 Mail Pound Sterling Cloudflare CDN
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Geospace Research
Geospace Research develops ultrasound systems for the diagnosis of a variety of medical pathologies.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Post-IPO Debt - TriSalus Life Sciences
Partisan Management Group
Partisan Management Group investment in Series D - TriSalus Life Sciences
ORI Capital
ORI Capital investment in Series D - TriSalus Life Sciences
MCG Capital
MCG Capital investment in Series C - TriSalus Life Sciences
High Country Venture
High Country Venture investment in Series C - TriSalus Life Sciences
Tullis Health Investors
Tullis Health Investors investment in Series C - TriSalus Life Sciences
KMG Capital Partners
KMG Capital Partners investment in Series C - TriSalus Life Sciences
Partisan Management Group
Partisan Management Group investment in Series C - TriSalus Life Sciences
High Country Venture
High Country Venture investment in Series B - TriSalus Life Sciences
MCG Capital
MCG Capital investment in Series B - TriSalus Life Sciences
Official Site Inspections
http://www.trisaluslifesci.com Semrush global rank: 8.16 M Semrush visits lastest month: 625
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "TriSalus Life Sciences"
About TriSalus Life Sciences®
TriSalus Life Sciences ® was established to develop and commercialize disruptive drug delivery technology for the treatment of liver and pancreatic tumors. Our proprietary Pressure-Enabled …See details»
SEC Filing - TriSalus Life Sciences, Inc. - investors.trisaluslifesci.com
On April 20, 2025, George Kelly Martin informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of …See details»
News & Events - Trisalus
Mar 27, 2025 As the first and largest cancer research organization dedicated to accelerating the conquest of cancer, AACR fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings; …See details»
TriSalus Life Sciences (TLSIW) Company Profile & Description
Apr 17, 2025 Company profile for TriSalus Life Sciences, Inc. (TLSIW) stock, with a description, list of executives, contact details and other key facts.See details»
TriSalus Life Sciences 2025 Company Profile: Stock …
Oct 20, 2022 Information on stock, financials, earnings, subsidiaries, investors, and executives for TriSalus Life Sciences. Use the PitchBook Platform to explore the full profile.See details»
TriSalus Life Sciences Company Profile - Craft
Oct 29, 2024 TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors. Its …See details»
TriSalus Life Sciences Names Chief Business Officer - Tullis Funds
The company created the Pressure-enabled Drug Delivery (PEDD) technology and is committed to developing other applications of the technology for use in other solid tumors and for the …See details»
TriSalus Life Sciences - Company Profile & Staff Directory
TriSalus Life Sciences is an immunotherapy company on a mission to extend and improve the lives of patients living with liver and pancreatic tumors. TriSalus' organ-specific platform …See details»
TriSalus Life Sciences CEO and Key Executive Team | Craft.co
TriSalus Life Sciences's Director is Anil Singhal. Other executives include Mary Szela, Chief Executive Officer, President and Director; Steven Katz, Chief Medical Officer and Chairman …See details»
TriSalus Life Sciences Completes Merger with MedTech Acquisition ...
Aug 10, 2023 In partnership with leading cancer centers across the country – and by leveraging deep immuno-oncology expertise and inventive technology development – TriSalus is …See details»
SEC Filing - TriSalus Life Sciences, Inc. - investors.trisaluslifesci.com
Apr 11, 2025 We are subject to the information reporting requirements of the Exchange Act, and we file reports, proxy statements, and other information with the SEC. These reports, proxy …See details»
TriSalus Life Sciences Expands Clinical Executive Team and …
Feb 10, 2022 DENVER and CHICAGO, February 10, 2022 – TriSalus Life Sciences ®, an immunotherapy company on a mission to improve the lives of patients living with liver and …See details»
TriSalus Life Sciences Announces Key Appointments to Board of …
DENVER, February 03, 2025--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a biomedical technology company seeking to transform outcomes for patients with solid tumors by …See details»
Contact - Trisalus
Contact TriSalus for general inquiries, investor relations, sales support, clinical trials information, and media relations.See details»
TriSalus Life Sciences, Inc. (TriSalus Life Sciences, Inc.) - 药物管线_ …
In partnership with leading cancer centers across the country – and by leveraging deep immuno-oncology expertise and inventive technology development – TriSalus is committed to …See details»
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial …
Mar 27, 2025 In partnership with leading cancer centers across the country – and by leveraging deep immuno-oncology expertise and inventive technology development – TriSalus is …See details»
TriSalus Life Sciences Opens Its First Research ... - Tullis Funds
Apr 12, 2022 TriSalus Life Sciences Opens Its First Research Laboratory on Lifespan Health System’s Campus Immunotherapeutic collaboration will advance efforts to develop new …See details»
TriSalus Life Sciences Opens Its First Research Laboratory on …
Apr 12, 2022 Immunotherapeutic collaboration will advance efforts to develop new treatment options for patients with liver and pancreatic tumors PROVIDENCE, R.I., April 12, 2022 – …See details»
The science behind the lifesum app: an intervention design …
4 days ago These are not mere pastime trinkets, but are expected by the World Health Organization to play an important role in managing health 10, and although the efficacy is still …See details»
Platform - Trisalus
Based on the scientific understanding of immune dysfunction, TriSalus’ platform takes an integrated approach to treating liver and pancreatic tumors.See details»